Xpert Perspectives: New Insights into the Recognition and Management of FGIMDs 2015

 

Didactic Lecture

Viewing Options

Webcast

Topic Information

Goal Statement

This activity has been designed to meet the educational needs of gastroenterologists, physician assistants, and nurse practitioners involved in the management of FGIMDs.

Target Audience

The CME meeting series will target gastroenterologists, nurse practitioners, physician assistants, and allied health care professionals managing patients with FGIMDs.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Describe recent data examining the economic burden of irritable bowel syndrome (IBS)

Discuss the most recent evidence regarding the value of breath testing for small intestinal bacterial overgrowth (SIBO) in patients with IBS

Discuss the latest evidence regarding the use of new and emerging therapies for IBS-D

Discuss the latest evidence regarding the use of new and emerging therapies for IBS-C

Credit Designation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the GI Health Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Release Date: November 15, 2015
Expiration Date: November 15, 2016   
*This program has expired. CME credit is no longer available.

Disclosure

All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Supported by an educational grants from Commonwealth Laboratories, Inc., Prometheus Laboratories, QOL Medical Laboratories, Inc., Salix Pharmaceuticals, Inc., Takeda Pharmaceuticals International, Inc., U.S. Region and Sucampo.

© Copyright 2013-2017 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.